Ventricular tachycardia and long QT associated with clarithromycin administration in a patient with HIV infection;Taquicardia ventricular y QT largo asociados a la administración de claritromicina en un paciente afectado de infección por el VIH

Revista Espanola de Cardiologia

Volumn 55, Issue 8, 2002, Pages 878-881

  Camazón, Nuria Vallejo ^a   Rodríguez Pardo, Dolores ^b   Hidalgo, Antonio Sánchez ^a   Tornos Mas, María Pilar ^b   Ribera, Esteban ^b   Soler Soler, Jordi ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Programa de Enfermedades Infecciosas   (Spain)

Author keywords

Clarithromycin; HIV; Long QT; Torsade de pointes; Ventricular tachyarrhythmias

Indexed keywords

ANTIRETROVIRUS AGENT; CEFEPIME; CLARITHROMYCIN; COTRIMOXAZOLE; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BLOOD GAS ANALYSIS; CASE REPORT; ELECTROCARDIOGRAM; HEART VENTRICLE TACHYCARDIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE DIFFERENTIAL COUNT; LONG QT SYNDROME; MALE; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; FOLLOW UP; TIME;

ADULT; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; ELECTROCARDIOGRAPHY; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LONG QT SYNDROME; MALE; TACHYCARDIA, VENTRICULAR; TIME FACTORS;

EID: 0036667509     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-8932(02)76720-1     Document Type: Article

References (12)

1. Shimizu H, Ohnishi Y, Inoue T, Yokoyama M. QT and JT dispersion in patients with monomorphic or polymorphic ventricular tachycardia/ventricular fibrillation. J Electrocardiol 2001;34:119-25.
2. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated miocardiopathy and detection of HIV in myocardial cells of HIV-positive patients. N Engl J Med 1998;339:1093-9.
3. Kocheril AG, Bokhari SA, Batsford WP, Sinusas AJ. Long QTc and torsades de pointes in human immunodeficiency virus disease. Pacing Clin Electrophysiol 1997;20:2810-6.
4. Villa A, Foresti V, Confalonieri F. Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection. Clin Auton Res 1995;5:48-52.
5. López JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T. QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. Am J Cardiol 1987;59:376-7.
6. Girgis I, Gualberti J, Langan L, Malek S, Mustaciolo V, Costantino T, et al. A prospective study of the effect of i.v. pentamidine therapy on ventricular arrhythmias and QTc prolongation in HIV-infected patients. Chest 1997;112:646-53.
7. Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsade de pointes. Ann Intern Med 1995;122:701-14.
8. Brandriss MW, Richardson WS, Barold SS. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsades de pointes): case report and review. Clin Infect Dis 1994;18:995-8.
9. Haefeli WE, Schoenenberger RA, Weiss P, Ritz R. Possible risk for cardiac arrhythmia related to intravenous erythromycin. Intensive Care Med 1992;18:469-73.
10. Ohtani H, Taninaka C, Hanada E, Kotaki H, Sato H, Sawada Y, et al. Comparative pharmacodinamic anakysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. Antimicrob Agents Chemother 2000;40:2630-7.
11. Lee KL, Jim MH, Tang SC, Tai YT. QT prolongation and torsades de pointes associated with clarithromycin. Am J Med 1998; 104:395-6.
12. Aguilera B, Suárez Mier MP, Morentin B. Miocardiopatía arritmogénica como causa de muerte súbita en España. Presentación de 21 casos. Rev Esp Cardiol 1999;52:656-62.